News Sanofi backs precision oncology firm Nucleai in $33m fundrai... Israeli startup Nucleai has raised $33 million in a second-round financing that will be used to further its work on using artificial inte
News AI startup Nucleai has immuno-oncology treatment failures in... Israeli company Nucleai is putting artificial intelligence to work to discover why so many cancer patients don’t respond to immunotherapies, with the help of Swiss drugmaker De
News Incyte blocks US launch of Sun Pharma's alopecia drug A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.